Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study
暂无分享,去创建一个
S. Safdar | A. Rehman | U. Groselj | F. Gul | Mujtaba Hasan | Sumera Nawaz Qabulio | M. A. Rana | Nousheen Fatima | M. Mlinaric | Muhammad Ali | K. Zehra | J. Alam | Tehzeeb Zehra | Arzu Jadoon | S. Khan | Q. Ain | A. Khan | S. Shafi | F. Sadiq | Saeedullah Shah | J. Sikonja | A. Munir | Habibur Rehman | M. Khan | S. Kidwai | Jamal Anwer | Shireen Qassim Bham | Maryam Haroon | Gul Zaman Khan Niazi | S. Gidding | Madeeha B. Khan | S. Hameed | Waheed Akhtar Awan | Shazia Jamil | Muhammad Talha Bin Nazir | Tanzeel Ur Rehman Ahmed Sheikh | Abeer Yousuf | Quratul Ain
[1] S. Gidding,et al. PAEDIATRIC FAMILIAL HYPERCHOLESTEROLAEMIA SCREENING IN EUROPE - PUBLIC POLICY BACKGROUND AND RECOMMENDATIONS. , 2022, European journal of preventive cardiology.
[2] O. Kordonouri,et al. Universal screening for familial hypercholesterolemia in 2 populations. , 2022, Genetics in medicine : official journal of the American College of Medical Genetics.
[3] A. Alrashidi,et al. Gaps in knowledge and practice for familial hypercholesterolemia among physicians caring for children in Saudi Arabia. , 2022, European review for medical and pharmacological sciences.
[4] G. Francis,et al. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study , 2022, The Lancet.
[5] G. Francis,et al. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) , 2021, The Lancet.
[6] Z. Saleem,et al. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology , 2021, Frontiers in Pharmacology.
[7] ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.
[8] C. Aguilar-Salinas,et al. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. , 2020, JAMA cardiology.
[9] P. Duell,et al. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia , 2019, Journal of the American Heart Association.
[10] G. Hindricks,et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.
[11] H. Rashid,et al. Awareness of Familial Hypercholesterolemia Among Healthcare Providers Involved in the Management of Acute Coronary Syndrome in Victoria, Australia , 2019, CJC open.
[12] S. Dwivedi,et al. Familial Hypercholesterolemia (FH) Awareness amongst Physicians in Mumbai, India. , 2019, The Journal of the Association of Physicians of India.
[13] G. Watts,et al. Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional training. , 2018, Atherosclerosis.
[14] T. Battelino,et al. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review. , 2018, Atherosclerosis.
[15] R. Pal,et al. India achieves WHO recommended doctor population ratio: A call for paradigm shift in public health discourse! , 2018, Journal of family medicine and primary care.
[16] N. Danchin,et al. Hypercholestérolémie familiale peu diagnostiquée, insuffisamment traitée. Enquête auprès de 495 médecins. , 2018, La Presse Médicale.
[17] H. Elsey,et al. The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review. , 2018, Value in health regional issues.
[18] S. Yamashita,et al. An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study” , 2017, BMJ Open.
[19] B. Nordestgaard,et al. Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world? , 2017, European heart journal.
[20] J. Borén,et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment , 2015, European heart journal.
[21] J. Foody. Familial Hypercholesterolemia: An Under‐recognized but Significant Concern in Cardiology Practice , 2014, Clinical cardiology.
[22] OUP accepted manuscript , 2022, European Heart Journal.
[23] M. Krempf,et al. [Familial hypercholesterolemia: An under-diagnosed and under-treated disease. Survey of 495 physicians]. , 2018, Presse medicale.